ADLAI NORTYE LTD.
Last · NASDAQ$10.88-0.875 (-7.44%)close · yahoo · 11h ago
Market cap$700.65M58.7M sh
P/E · TTM-14.9fwd -37.0 · eps -0.73 · loss
Beta1.11vs S&P 500
Div yield0.00%annual · TTM
52w range
$0.879$17.25
Volume378.0Ksession
| Revenue | $5.0M |
|---|---|
| Operating income | $-35.7M |
| Net income | $-35.5M |
| Free cash flow | $-33.6M |
| Operating margin | -714.0% |
| Net margin | -710.6% |
| Period | 2025 |
Loading chart…
OpenFilings analyst
Our analyst
From latest 20-F · 2026-04-10
- Operating Cf Burn
- Net Margin Sharply Negative
- Cash Conversion Weak
- Cash Runway Low
- Rd Intensity High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -710.6%
- Cash Conversion Weak — Cash conversion (CFO/Rev) -669.0%
- Cash Runway Low — Cash runway ~0.2 years
- Rd Intensity High — R&D/Revenue 656.7%
Press & signals
- GlobeNewswire
Adlai Nortye Appoints Christopher Liu, PharmD, as Head of Investor Relations and Public Relations
- GlobeNewswire
Adlai Nortye Ltd. Reports Unaudited First Half 2026 Financial Results and Highlights Recent Operational Progress
- GlobeNewswire
Adlai Nortye Expands Scientific Advisory Board with Appointment of Two Leading Medical Oncologists
The rest of this company's wire — with summaries and source links — is part of Pro.
See plans